Skip to main content
Figure 6 | BMC Cancer

Figure 6

From: Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells

Figure 6

Effects of the combination of ACR and LY294002 on the cellular expression levels of RARβ, p21 CIP1 , and cyclin D1 in HLF cells. (A) The expression levels of RARβ mRNA (left panel) and protein (right panel) were examined by quantitative real-time RT-PCR analysis and western blot analysis, respectively, using cells treated with the test drugs for 24 hours. (B) Quantitative real-time RT-PCR analysis to examine the expression levels of p21CIP1 and cyclin D1 mRNAs were performed using cells treated with the test drugs for 24 hours. The expression level of each mRNA was normalized to the level of β-actin mRNA. Values represent the means ± SD of triplicate analyses. * P < 0.05.

Back to article page